Benzodiazepine Prescription Rates Dropped Over Decade
The annual rate of dispensed benzodiazepine prescriptions fell by 26.7% across the United States between 2013 and 2023.
Updated on Oct. 6, 2026 in Substance Abuse
Live Poll
Do you trust that current medical guidelines for prescribing addictive medications are sufficiently protective of patients?
Data from the IQVIA Longitudinal Prescription dataset reveals a steady decline in benzodiazepine usage, falling from 7.5% to 5.5% of the population over a decade. This trend, which concludes with 2024 data, marks a significant shift in how these medications are managed nationally.
Why it matters
The reduction suggests a widespread change in clinical prescribing patterns across various specialties. Understanding these shifts helps clarify evolving standards in long-term medication safety and psychiatric care.
This analysis of over 1.1 billion prescription fills found a 26.7% decrease in annual benzodiazepine prevalence. While most specialties saw double-digit reductions, prescriptions by advanced practice providers rose by 101.5%.
The players
American Journal of Psychiatry
A peer-reviewed medical journal that publishes research on clinical psychiatry and mental health.
The details
The analysis tracked over 1.1 billion prescription fills to identify shifts in dosing and provider habits. While pain specialists and primary care physicians significantly curtailed their prescribing volume, advanced practice providers saw a notable increase in dispensed prescriptions. Mean total doses per prescription also decreased across all cohorts, with the largest drop of 65.3% occurring among pain medicine specialists.
Timeline
2013: Beginning of the study period.
2023: End of the prevalence measurement period.
2024: End of the study data collection period.
September 30, 2026: Study published in the American Journal of Psychiatry.
Health Landscape
The study updates the historical trend of benzodiazepine prescribing in the United States by providing the most recent decade-long data analysis. It serves as a benchmark for assessing shifts in outpatient mental health and pain management practices.
If you are currently taking a benzodiazepine, the decrease in mean dose per prescription highlights the importance of regular medication reviews. It is worth discussing with your doctor how your current treatment plan aligns with updated clinical standards.
The takeaway
Nationwide prescription patterns indicate a clear shift toward lower benzodiazepine utilization and lower dosing per fill over the last decade. Discussing your medication goals and potential alternatives with a qualified physician is the safest way to manage your care.
Further reading
For broader context on medication safety and oversight, explore our Substance Abuse section.
Live Poll
Do you trust that current medical guidelines for prescribing addictive medications are sufficiently protective of patients?
